Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations

Rhoden, A; Schulze, T; Pietsch, N; Christ, T; Hansen, A; Eschenhagen, T

Rhoden, A; Eschenhagen, T (通讯作者),Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Inst Expt Pharmacol & Toxicol, Hamburg, Germany.;Rhoden, A; Eschenhagen, T (通讯作者),Univ Med Ctr Hamburg Eppendorf, German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2022; 322 (3): H373

Abstract

Omecamtiv mecarbil (OM), a myosin activator, was reported to induce complex concentration-and species-dependent effects on contractile function, and c......

Full Text Link